A leading private equity player

The power of and

Companies must face multiple challenges to innovate, grow and adapt to a rapidly changing environment. It has been Andera Partners’ mission for over 20 years to help companies and their management achieve strong and sustainable growth. Our conviction, at the heart of our commitment, our partnership and our way to work with entrepreneurs, is that to grow and develop, it is essential to have the right partners and enjoy working together. The Power of And thus becomes Andera Partners’ signature that relays our conviction.

Our commitments Our investments

4 billion under management

300 companies supported in over 20 years

110 professionals

Our Activities

Andera Partners is an asset management firm specialising in Private Equity. We draw on our expertise in various areas to provide a range of well-defined investment strategies. Our goal is to provide bespoke solutions to meet the challenges faced by leaders and their business models.

Our activities

Our Latest News

Below you will find all the latest news on Andera Partners, its teams and its investments.

30.11.2023 - andera Infra - News Infra - Press releases

mylight150 secures €100m to accelerate the expansion of its solar self-consumption & smart ener…

Combined Shape

14.11.2023 - andera Life Sciences - Press releases

Andera Partners co-leads a €67.5 million ($72 million) oversubscribed Series C round for cancer immu…

Combined Shape

13.11.2023 - andera Acto - Press releases

Andera Partners joins forces with Founders of Gosto Group in providing support in their internationa…

Combined Shape

27.10.2023 - andera Life Sciences - Press releases

JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy E…

Combined Shape

11.10.2023 - andera Life Sciences - Press releases

Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline

Combined Shape

10.10.2023 - andera Expansion/Croissance - Press releases

ELAN Languages acquires Dutch company AVB Vertalingen

Combined Shape

05.10.2023 - andera Life Sciences - Press releases

Agomab Receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and Starts…

Combined Shape

05.10.2023 - andera Acto - Press releases

Andera Acto supports EFOR’s ambition of becoming a global leader in its market within five yea…

Combined Shape

04.10.2023 - andera Acto - Press releases

Andera Partners completes full exit from Travelsoft Group and hands over to CAPZA

Combined Shape

18.09.2023 - andera MidCap - Press releases

Andera Partners increases the hard cap for Andera MidCap 5 and raises a final amount of €750 million

Combined Shape

24.07.2023 - andera Life Sciences - Press releases

Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumo…

Combined Shape

11.07.2023 - Andera Partners - Sustainability - Publications

2022 Sustainability Report

Combined Shape

06.07.2023 - andera MidCap - Press releases

PAI Partners to acquire majority stake in Infra Group

Combined Shape

04.07.2023 - andera Expansion/Croissance - Press releases

ELAN Languages completes acquisition of German group Lingua-World GmbH

Combined Shape

29.06.2023 - andera Acto - Press releases

Andera Acto supports Auris Group in restructuring of its capital and in its development strategy

Combined Shape
Our Latest News